Between evidence and commerce - the case of sufentanil sublingual tablet systems
Anaesthesia
.
2018 Feb;73(2):143-147.
doi: 10.1111/anae.14037.
Epub 2017 Dec 8.
Authors
C Bantel
1
2
,
H C Laycock
2
Affiliations
1
Pain Medicine and Anaesthesia, Klinikum Oldenburg AöR, Oldenburg, Germany.
2
Imperial College London, London, UK.
PMID:
29219168
PMCID:
PMC5814728
DOI:
10.1111/anae.14037
No abstract available
Keywords:
conflict of interest; pain; sublingual sufentanil.
Publication types
Editorial
Comment
MeSH terms
Analgesia, Patient-Controlled
Analgesics, Opioid
Gabapentin*
Sufentanil*
Tablets
Substances
Analgesics, Opioid
Tablets
Gabapentin
Sufentanil